Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

tment and DEA are trying to scapegoat it for the government's regulatory and enforcement failures with regard to the opioid crisis. The AP_ (10/22, D'Innocenzio) calls Walmart's lawsuit "a pre-emptive strike in the battle over its responsibility in the opioid abuse crisis. The government is expected to take

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

enforcement failures with regard to the opioid crisis. The AP <https://apnews.com/article/lawsuits-opioids-e9e7b85513ae75ce421d70a21c4dd8f7> (10/22, D'Innocenzio) calls Walmart's lawsuit "a pre-emptive strike in the battle over its responsibility in the opioid abuse crisis. The government is expected to take

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

rtment and DEA are trying to scapegoat it for the government's regulatory and enforcement failures with regard to the opioid crisis. The AP (10/22, D'Innocenzio) calls Walmart's lawsuit "a pre-emptive strike in the battle over its responsibility in the opioid abuse crisis. The government is expected to take